Gedeon Richter Agrees to Buy Mayne Pharma for A$604 Million
Mayne Pharma said Gedeon Richter agreed to acquire the Australian firm for an equity value of about A$604 million ($407.76 million). Mayne Pharma shares rose 86% to a one-year high.
Mayne Pharma ASX:MYX said on Tuesday that Hungarian drugmaker Gedeon Richter BET:RICHTER had agreed to buy the Australian firm for an equity value of about A$604 million ($407.76 million), sending its shares soaring 86% to a one-year high.The deal put the stock on track for its best session on reco…